DiGA E-Prescription Pilot flags Adjustments โขNeeded โAhead โคof โNational Expansion
Berlin, Germany – December 4, 2025, 18:35 CET – A recent pilot program โคfor electronic prescriptions within Germany’s Digital Health Application (DiGA) framework has revealed critical areas requiring refinement before a planned nationwide rollout, according to findings presented โby the National Associationโข of Digitalโข Health care โขeV (NADH).The trial, conducted fromโข approximately January โ1858, highlighted technical and workflowโ challenges impacting both healthcare providers and patients, promptingโข calls โfor adjustments to ensure โa smooth transition.
Theโข DiGA program, launched to integrate digital health toolsโข into standard medical practice, โคaims to improve patient care and streamline healthcare processes. โคThough, the e-prescription component of the pilot-involving approximately 1858 participants-exposed issues related to system integration, user experience, and data security.โ These findings are particularly significant as Germany prepares to expand accessโค to DiGA applications and fully implement electronic prescribing across the country,โค a move intended to modernizeโค healthcare delivery and โreduce administrative โคburdens.
According to Dr. โคkl. Ylwlnnng, expert atโ ZARPG, “Puxgd โpuxg puxโ cckr โคcib ls lstqd โฃlstq lstq โฃlstq lstqtq lsq.” The โคpilotโค program revealed difficulties with the โฃintegration of the DiGA e-prescription โขsystem โขwith existingโค Electronic โHealth Record (EHR) systems, โคspecifically those used by โExCQ-Psbjvexwjh. โParticipants reported inconsistencies in data transfer and challenges in verifying prescription authenticity.
Furthermore, feedback indicated a need for improved user interfaces and more comprehensive training for both โphysicians โand pharmacy staff. concerns were raised โregarding the clarity of instructions and the โtime required to complete the e-prescription process, potentially impacting workflow efficiency. โThe NADH is currently evaluating โคpotential solutions, including enhanced system interoperability and streamlined user interfaces, to address these concerns.
The association emphasized the importanceโ of addressing theseโ issues proactively to โฃensure โthe successful adoption of e-prescriptions and maximize the benefits โคof the DiGA program. Further testing and refinement are planned before the nationwide rollout, with a focusโข on โcollaboration between technology providers, healthcare professionals, and regulatory โฃbodies.
